BSE:539981

Stock Analysis Report

Executive Summary

Max India Limited, an investment company, provides various healthcare services in India and internationally.

Snowflake

Fundamentals

Mediocre balance sheet with limited growth.

Share Price & News

How has Max India's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

5.8%

539981

3.7%

IN Healthcare

2.4%

IN Market


1 Year Return

-2.9%

539981

13.1%

IN Healthcare

8.0%

IN Market

Return vs Industry: 539981 underperformed the Indian Healthcare industry which returned 13.1% over the past year.

Return vs Market: 539981 underperformed the Indian Market which returned 8% over the past year.


Shareholder returns

539981IndustryMarket
7 Day5.8%3.7%2.4%
30 Day9.7%5.1%2.5%
90 Day9.6%14.9%3.6%
1 Year-2.9%-2.9%13.7%13.1%10.3%8.0%
3 Year-53.5%-53.5%-6.1%-7.2%22.3%16.0%
5 Yearn/a32.7%30.4%42.8%29.3%

Price Volatility Vs. Market

How volatile is Max India's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Max India undervalued compared to its fair value and its price relative to the market?

45.57x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 539981 (₹65.95) is trading above our estimate of fair value (₹1.01)

Significantly Below Fair Value: 539981 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 539981 is poor value based on its PE Ratio (45.6x) compared to the Healthcare industry average (21.4x).

PE vs Market: 539981 is poor value based on its PE Ratio (45.6x) compared to the Indian market (13x).


Price to Earnings Growth Ratio

PEG Ratio: 539981's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: 539981 is good value based on its PB Ratio (1.5x) compared to the IN Healthcare industry average (1.9x).


Next Steps

Future Growth

How is Max India forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

-110.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 539981's earnings are forecast to decline over the next 3 years (-110.3% per year).

Earnings vs Market: 539981's earnings are forecast to decline over the next 3 years (-110.3% per year).

High Growth Earnings: 539981's earnings are forecast to decline over the next 3 years.

Revenue vs Market: 539981's revenue (79.2% per year) is forecast to grow faster than the Indian market (11.3% per year).

High Growth Revenue: 539981's revenue (79.2% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 539981's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Max India performed over the past 5 years?

56.3%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: 539981's earnings have grown significantly by 56.3% per year over the past 5 years.

Accelerating Growth: 539981 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 539981 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (13.6%).


Return on Equity

High ROE: 539981's Return on Equity (-3.4%) is considered low.


Return on Assets

ROA vs Industry: 539981's Return on Assets is below or equal to the Healthcare industry average last year.


Return on Capital Employed

ROCE Improving: 539981 is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Max India's financial position?


Financial Position Analysis

Short Term Liabilities: 539981's short term assets (₹13.3B) exceeds its short term liabilities (₹8.6B)

Long Term Liabilities: 539981's short term assets (13.3B) exceeds its long term liabilities (1.9B)


Debt to Equity History and Analysis

Debt Level: 539981's debt to equity ratio (15.1%) is considered satisfactory

Reducing Debt: Insufficient data to determine if 539981's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: 539981's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if 539981's interest payments on its debt are well covered by EBIT.


Balance Sheet

Inventory Level: 539981 has a low level of unsold assets or inventory.

Debt Coverage by Assets: 539981's debt is covered by short term assets (assets are 6.868800x debt).


Next Steps

Dividend

What is Max India's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%0.6%markettop25%2.4%industryaverage0.7%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate 539981's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate 539981's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if 539981's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 539981's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 539981's dividend in 3 years as they are not forecast to pay a notable one for the Indian market.


Next Steps

Management

What is the CEO of Max India's salary, the management and board of directors tenure and is there insider trading?

3.5yrs

Average management tenure


CEO

Mohit Talwar (60yo)

3.8yrs

Tenure

₹20,182,316

Compensation

Mr. Mohit Talwar has been Managing Director of Max Financial Services Limited and Max India Limited since January 15, 2016. He has been Group Vice Chairman at Max India Limited since April 1, 2019. Mr. Tal ...


CEO Compensation Analysis

Compensation vs. Market: Insufficient data to establish whether Mohit's total compensation is reasonable compared to companies of similar size in the Indian market.

Compensation vs Earnings: Mohit's compensation has been consistent with company performance over the past year.


Management Age and Tenure

3.5yrs

Average Tenure

52yo

Average Age

Experienced Management: 539981's management team is considered experienced (3.5 years average tenure).


Board Age and Tenure

1.9yrs

Average Tenure

63yo

Average Age

Experienced Board: 539981's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Analjit Singh (65yo)

    Founder & Chairman

    • Tenure: 0.5yrs
    • Compensation: ₹200.00k
  • Patnam Dwarakanath (72yo)

    Head of Group Human Capital

    • Tenure: 3.8yrs
  • Rahul Khosla (60yo)

    Group Advisor

    • Tenure: 0.5yrs
    • Compensation: ₹1.70m
  • Mohit Talwar (60yo)

    Group Vice Chairman

    • Tenure: 3.8yrs
    • Compensation: ₹20.18m
  • Nitin Thakur (47yo)

    Director of Brand & Communications

    • Tenure: 3.8yrs
  • Dilbagh Narang (48yo)

    Director of Taxation

    • Tenure: 2.4yrs
    • Compensation: ₹3.69m
  • Pradeep Chadha (52yo)

    Deputy Director of Finance & Treasury

    • Tenure: 0yrs
    • Compensation: ₹3.48m
  • Rishi Raj (42yo)

    Director of Strategy & Corporate Development

    • Tenure: 3.5yrs
  • Sandeep Pathak (39yo)

    Chief Financial Officer

    • Tenure: 0.3yrs
  • Pankaj Chawla

    Deputy GM of Secretarial

    • Tenure: 0yrs

Board Members

  • Analjit Singh (65yo)

    Founder & Chairman

    • Tenure: 0.5yrs
    • Compensation: ₹200.00k
  • Kummamuri Murthy (62yo)

    Independent Director

    • Tenure: 0.8yrs
    • Compensation: ₹200.00k
  • Ashwani Windlass (63yo)

    Non Executive Director

    • Tenure: 3.8yrs
    • Compensation: ₹1.80m
  • Mohit Talwar (60yo)

    Group Vice Chairman

    • Tenure: 3.8yrs
    • Compensation: ₹20.18m
  • Dinesh Mittal (66yo)

    Independent Director

    • Tenure: 2.9yrs
    • Compensation: ₹2.70m
  • Ashok Kacker

    Independent Director

    • Tenure: 3.8yrs
    • Compensation: ₹3.30m
  • Tara Vachani (32yo)

    Non Executive Director

    • Tenure: 3.8yrs
    • Compensation: ₹700.00k
  • Sharmila Tagore (75yo)

    Independent Director

    • Tenure: 0.7yrs
    • Compensation: ₹100.00k

Company Information

Max India Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Max India Limited
  • Ticker: 539981
  • Exchange: BSE
  • Founded: 2015
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: ₹17.571b
  • Shares outstanding: 268.67m
  • Website: https://www.maxindia.com

Location

  • Max India Limited
  • Max House
  • 1, Dr. Jha Marg
  • New Delhi
  • Delhi
  • 110020
  • India

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
539981BSE (Mumbai Stock Exchange)YesEquity SharesININRJul 2016
MAXINDIANSEI (National Stock Exchange of India)YesEquity SharesININRJul 2016

Biography

Max India Limited, an investment company, provides various healthcare services in India and internationally. The company operates through Business Investments, Senior Living, Learning and Development, Heal ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/23 12:49
End of Day Share Price2019/10/23 00:00
Earnings2019/06/30
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.